Stocks to sell

Talk of Clover Health (NASDAQ:CLOV) stock being a great short-squeeze play is making the rounds once again. Source: Shutterstock So, should you buy into the insuretech play now at around $8.50 per share, in anticipation of it zooming back to $20 per share and beyond? Not so fast. It may still be one of the

When Clover Health (NASDAQ:CLOV) tested multiple bottoms from March to May, it set up a technical June rally next. Hindsight is 20/20 and does not make money. Speculators now know the CLOV stock spike from $8 to $28.85 in June would not last. Source: Shutterstock Bears are not done betting against Clover. The short float

Contrary to the belief of many commentators, I think that the outlook of Carnival Corporation (NYSE:CCL) stock has improved in recent weeks. Source: Ruth Peterkin / Shutterstock.com Despite the negative impact of the Delta variant of the novel coronavirus, other, positive factors or Carnival, are, for now, outweighing the latest outbreak. Still, I believe that

Marin Software (NASDAQ:MRIN), which makes enterprise software for the advertising industry, cratered over the last month. I think it is likely to still drop further. MRIN stock closed at $14.45 on July 12 when I wrote that it was likely to drop much further. At the close on Aug. 12, it was at $5.67 and

I have written two articles about Ocugen (NASDAQ:OCGN) in the past and I must say that if I had to summarize OCGN stock in two words, they would be irrational exuberance. Source: shutterstock.com/PhotobyTawat As of August 9, 2021, the company has a market valuation of $1.61 billion with zero revenue for 2019 and 2018. Yahoo!

If you visit the website of a publicly traded company and within a very short time you cannot understand the nature of its business, there’s a big problem. That’s the case with Vinco Ventures (NASDAQ:BBIG). The company’s profile isn’t concise. With that in mind, let’s take a closer look at some things to consider before

Senseonics Holdings (NYSEAMERICAN:SENS) develops medical technology, including “continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.” The company’s product line includes implantable CGM systems that go under the user’s skin and a removable, rechargeable transmitter that works with an app made by the company. SENS

Shopify (NYSE:SHOP) has enjoyed a stellar runup in the past three months. As of Aug. 10, SHOP stock was at $1,525.94 with a $190.4 billion market capitalization. This was up 45.6% from its May 13 low close at $1,047.77, probably in anticipation of the company’s Q2 earnings. Source: Beyond The Scene / Shutterstock.com The problem

With cryptos bouncing back, mining plays like SOS Limited (NYSE:SOS) stock are coming back into the spotlight. But are shares in the China-based crypto mining company the way to play a possible continued recovery for Bitcoin (CCC:BTC-USD)? Not so fast. Source: biggunsband / Shutterstock.com Even before the crypto meltdown in May, SOS appeared to be

Every time that I’m asked to write about Ocugen (NASDAQ:OCGN) I must remind myself that OCGN stock was caught up in the meme-stock craze earlier this year. And with short interest in the stock still above 20%, I suppose there are several traders who have little choice other than to hold on and hope for the

Chinese stocks that ended up being targeted by Beijing have been pummeled in recent weeks. But after China’s government tried to reassure companies and investors that it was not trying to decimate the country’s stocks, some on Wall Street seem to believe that the government was giving the “all-clear” sign. But I don’t think that’s

Blackberry Limited (NYSE:BB), the Canadian IoT (Internet of Things) software and security company, has seen its stock tumble over the past month by about 10% or so. Moreover, BB stock is down from its recent closing peak of $15.88 on June 3 to $10.29 as of Aug. 6. That represents a drop of over 35%

Robinhood Markets (NASDAQ:HOOD) which just went public on Aug. 2, is unprofitable and not likely to see any net income until next year. The market might not exactly know this, especially since HOOD stock has risen over $20 since going public on July 29, closing at $34.82 on its first day. Source: mundissima / Shutterstock.com

Exela Technologies (NASDAQ:XELA) was drowning in debt and needed to do something drastic to cut its interest expenses. Source: Shutterstock In fact, on page 6 of its latest 10-Q filing, the company admitted that there was a “substantial doubt” about its ability to continue as a going concern. It was burdened by operating losses and

Palantir (NYSE:PLTR) is a company that I cannot find a better phrase to describe than the well-known “Houston, we have a problem.” PLTR stock made its debut in 2020 through a standard IPO and gained significant traction in early 2021. With a 52-week high price of $45, it has sold off that early traction in

Ashford Hospitality Trust (NYSE:AHT) claims to be “well-positioned to capitalize on the lodging recovery” its investor presentation. But judging by the price action of AHT stock, the shareholders have definitely not been capitalizing as they’ve struggled to get back to break even. Source: Shutterstock Regardless, the company claims to have a “clear path forward to capitalize

Putting it simply, Vinco Ventures (NASDAQ:BBIG) is the kind of penny stock that’s a hard pass in normal market conditions. But, of course, what we have seen play out in the past year has been anything but normal. With phenomena like “meme stock madness,” rolling the dice on something like BBIG stock has become a

Throughout 2021, I’ve been periodically weighing in on the original meme stock –GameStop (NYSE:GME). My message has been to have fun trading GME stock, but don’t buy and hold it for the long term. Source: quietbits / Shutterstock.com I’ve taken a lot of heat this year for simply pointing out that the share prices of

As longtime readers know, I’m a huge electric vehicle (EV) stock bull. I’m 100% confident that electric vehicles will entirely replace gas-powered by cars by 2040, thanks to improving EV technology, falling battery costs, shifting consumer demand to eco-friendly products, and increasing supply of EVs. At this point, the EV Revolution is inevitable, and EV

Meme stocks have dominated in 2021, and SOS Limited (NYSE:SOS) has benefited from the trend of irrational exuberance in investments. If you’re considering taking a position in SOS stock, there are a few things you should know first. Source: Mark Agnor / Shutterstock.com From its unfocused business model to its shaky fundamentals, SOS Limited is

Robinhood Markets (NASDAQ:HOOD) got off to a rocky start following its recent initial public offering. HOOD stock closed its first trading day down more than 8%. Source: OpturaDesign / Shutterstock.com In the days that followed, Robinhood has skyrocketed to more than double its $38 IPO price. There’s no question Robinhood has been a tremendous success

Last month, Marin Software (NASDAQ:MRIN) enjoyed a meme stock rally that made similar runs seem tame by comparison. But that doesn’t mean it’s wise to buy MRIN stock now as it crashes back to earth. The circumstances that helped the digital marketing software stock rise 16-fold aren’t likely to repeat themselves. Three factors worked in

The shares of clinical-stage biotech company Atossa Therapeutics (NASDAQ:ATOS) have been on a wild run in the past month. ATOS stock has lost  41% in the past month, despite a series of positive catalysts for the stock recently. Source: luchschenF / Shutterstock.com The company has multiple treatments in its pipeline, including Endoxifen, a drug that’s

Back in January, I covered Sundial Growers (NASDAQ:SNDL) and wrote a bearish article. Essentially, I called SNDL stock a gamble. Now, seven months later, things have not changed much. Source: Shutterstock Of course, it’s hard for a company to present enough news and positive financial performance to radically change an investment thesis over such a

Nio (NYSE:NIO) stock has an awful lot riding on its upcoming earnings report. Source: Sundry Photography / Shutterstock.com For any publicly traded company, earnings reports are critical as they present a showcase for stakeholders and prospective buyers. But for Nio, the financial disclosure for the second quarter will truly determine whether people can trust its

There’s a lot of good news out there. But there’s also a lot of unknowns that keep buffeting that optimism. The other X-factor in all this is how the market is going to take any of the new information that gets released. Will an expanding economy be a bullish sign and move the market up?

Bionano (NASDAQ:BNGO) is a small life sciences company. Biotech companies use Bionano’s Saphyr system for researching DNA and to diagnose illnesses caused by genetics. Up until recently, Bionano has had difficulty achieving widespread market adoption for Saphyr. However, BNGO stock has gone on a wild ride over the past year as traders gravitated to Bionano’s

Meta Materials (NASDAQ:MMAT) is a Canadian company that recently listed on the Nasdaq via a SPAC (special purpose acquisition corporation) reverse merger. To put it bluntly, MMAT stock is the kind of highly speculative stock you ought to avoid. Source: Shutterstock This high-tech company develops nanocomposite materials and products. The debt-free company announced it had closed

Other than a short-lived rally in June fueled by Reddit users, ContextLogic (NASDAQ:WISH) stock is on a permanent trajectory downward. Source: sdx15 / Shutterstock.com WISH stock peaked at $32.85, shortly after its initial public offering earlier this year. The company’s unfavorable valuations, mixed first-quarter results, and poor sales forecast continue to weigh on its share

With Covid-19 vaccination rates slowing around the world, now is not the time to buy biotechnology company Novavax (NASDAQ:NVAX) stock. Source: Ascannio/Shutterstock.com NVAX stock fell 10% between July 20 and July 27 as hope fades that the company will be able to get its Covid-19 vaccine to market in time to capitalize on demand for